Bausch Health Companies Inc. (BHC)
USD 4.34
(0.46%)
USD 4.34
(0.46%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 22.38 Billion USD | 7.81% |
| 2022 | 20.76 Billion USD | -8.33% |
| 2021 | 22.65 Billion USD | -5.31% |
| 2020 | 23.92 Billion USD | -7.61% |
| 2019 | 25.89 Billion USD | 5.13% |
| 2018 | 24.63 Billion USD | -3.19% |
| 2017 | 25.44 Billion USD | -14.77% |
| 2016 | 29.85 Billion USD | -4.02% |
| 2015 | 31.1 Billion USD | 103.82% |
| 2014 | 15.26 Billion USD | -12.19% |
| 2013 | 17.37 Billion USD | 57.62% |
| 2012 | 11.02 Billion USD | 65.78% |
| 2011 | 6.65 Billion USD | 80.18% |
| 2010 | 3.69 Billion USD | 840.99% |
| 2009 | 392.28 Million USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 411.77 Million USD | -5.76% |
| 2005 | 436.95 Million USD | -8.14% |
| 2004 | 475.65 Million USD | -42.2% |
| 2003 | 822.92 Million USD | 10.11% |
| 2002 | 747.35 Million USD | 1519.01% |
| 2001 | 46.16 Million USD | -93.75% |
| 2000 | 738.72 Million USD | 437.26% |
| 1999 | 137.5 Million USD | 8.35% |
| 1998 | 126.9 Million USD | 2489.8% |
| 1997 | 4.9 Million USD | -30.0% |
| 1996 | 7 Million USD | -31.37% |
| 1995 | 10.2 Million USD | -9.73% |
| 1994 | 11.3 Million USD | -47.69% |
| 1993 | 21.6 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 21.5 Billion USD | -0.69% |
| 2024 Q2 | 21.65 Billion USD | -1.79% |
| 2024 Q1 | 22.05 Billion USD | -1.5% |
| 2023 Q3 | 22.43 Billion USD | -17.64% |
| 2023 FY | 22.38 Billion USD | 7.81% |
| 2023 Q4 | 22.38 Billion USD | -0.19% |
| 2023 Q2 | 27.23 Billion USD | 31.87% |
| 2023 Q1 | 20.65 Billion USD | -0.54% |
| 2022 Q4 | 20.76 Billion USD | -2.12% |
| 2022 FY | 20.76 Billion USD | -8.33% |
| 2022 Q1 | 23.16 Billion USD | 2.27% |
| 2022 Q2 | 21.81 Billion USD | -5.84% |
| 2022 Q3 | 21.21 Billion USD | -2.75% |
| 2021 Q3 | 22.35 Billion USD | -4.61% |
| 2021 Q1 | 23.73 Billion USD | -0.78% |
| 2021 Q4 | 22.65 Billion USD | 1.32% |
| 2021 Q2 | 23.43 Billion USD | -1.26% |
| 2021 FY | 22.65 Billion USD | -5.31% |
| 2020 Q4 | 23.92 Billion USD | -1.72% |
| 2020 Q3 | 24.34 Billion USD | -0.06% |
| 2020 FY | 23.92 Billion USD | -7.61% |
| 2020 Q1 | 24.42 Billion USD | -5.67% |
| 2020 Q2 | 24.35 Billion USD | -0.29% |
| 2019 Q1 | 24.18 Billion USD | -1.83% |
| 2019 FY | 25.89 Billion USD | 5.13% |
| 2019 Q4 | 25.89 Billion USD | 9.88% |
| 2019 Q3 | 23.56 Billion USD | -2.13% |
| 2019 Q2 | 24.07 Billion USD | -0.42% |
| 2018 Q4 | 24.63 Billion USD | -0.4% |
| 2018 FY | 24.63 Billion USD | -3.19% |
| 2018 Q3 | 24.73 Billion USD | -1.42% |
| 2018 Q2 | 25.08 Billion USD | -0.71% |
| 2018 Q1 | 25.26 Billion USD | -0.69% |
| 2017 Q4 | 25.44 Billion USD | -6.25% |
| 2017 Q3 | 27.14 Billion USD | -4.64% |
| 2017 Q1 | 28.55 Billion USD | -4.36% |
| 2017 FY | 25.44 Billion USD | -14.77% |
| 2017 Q2 | 28.46 Billion USD | -0.32% |
| 2016 Q2 | 31.06 Billion USD | -2.85% |
| 2016 Q1 | 31.97 Billion USD | 2.81% |
| 2016 FY | 29.85 Billion USD | -4.02% |
| 2016 Q3 | 30.44 Billion USD | -2.0% |
| 2016 Q4 | 29.85 Billion USD | -1.95% |
| 2015 Q4 | 31.1 Billion USD | 0.71% |
| 2015 Q2 | 30.88 Billion USD | 18.68% |
| 2015 FY | 31.1 Billion USD | 103.82% |
| 2015 Q1 | 26.02 Billion USD | 70.51% |
| 2015 Q3 | 30.88 Billion USD | 0.01% |
| 2014 FY | 15.26 Billion USD | -12.19% |
| 2014 Q2 | 17.32 Billion USD | -0.35% |
| 2014 Q3 | 16.27 Billion USD | -6.06% |
| 2014 Q4 | 15.26 Billion USD | -6.23% |
| 2014 Q1 | 17.38 Billion USD | 0.04% |
| 2013 Q3 | 17.4 Billion USD | 61.24% |
| 2013 Q4 | 17.37 Billion USD | -0.14% |
| 2013 Q2 | 10.79 Billion USD | 1.67% |
| 2013 Q1 | 10.61 Billion USD | -3.71% |
| 2013 FY | 17.37 Billion USD | 57.62% |
| 2012 FY | 11.02 Billion USD | 65.78% |
| 2012 Q1 | 6.99 Billion USD | 5.19% |
| 2012 Q2 | 7.55 Billion USD | 7.93% |
| 2012 Q3 | 7.63 Billion USD | 1.05% |
| 2012 Q4 | 11.02 Billion USD | 44.51% |
| 2011 FY | 6.65 Billion USD | 80.18% |
| 2011 Q2 | 4.54 Billion USD | -3.6% |
| 2011 Q3 | 5.22 Billion USD | 14.96% |
| 2011 Q4 | 6.65 Billion USD | 27.25% |
| 2011 Q1 | 4.71 Billion USD | 27.77% |
| 2010 Q1 | 395.08 Million USD | 0.71% |
| 2010 FY | 3.69 Billion USD | 840.99% |
| 2010 Q3 | 3.23 Billion USD | 737.96% |
| 2010 Q4 | 3.69 Billion USD | 14.09% |
| 2010 Q2 | 386.12 Million USD | -2.27% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q4 | 392.28 Million USD | 0.0% |
| 2009 FY | 392.28 Million USD | 0.0% |
| 2009 Q1 | - USD | -100.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | 63.7 Million USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2007 Q2 | - USD | -100.0% |
| 2007 FY | - USD | -100.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q1 | 411.94 Million USD | 0.04% |
| 2007 Q4 | - USD | 0.0% |
| 2006 Q2 | 418.39 Million USD | -1.81% |
| 2006 FY | 411.77 Million USD | -5.76% |
| 2006 Q1 | 426.11 Million USD | -2.48% |
| 2006 Q3 | 424.37 Million USD | 1.43% |
| 2006 Q4 | 411.77 Million USD | -2.97% |
| 2005 Q3 | 447.33 Million USD | -0.24% |
| 2005 Q1 | 464.55 Million USD | -2.33% |
| 2005 Q2 | 448.39 Million USD | -3.48% |
| 2005 Q4 | 436.95 Million USD | -2.32% |
| 2005 FY | 436.95 Million USD | -8.14% |
| 2004 Q4 | 475.65 Million USD | -19.37% |
| 2004 Q2 | 643.94 Million USD | -9.74% |
| 2004 Q1 | 713.4 Million USD | -13.31% |
| 2004 Q3 | 589.9 Million USD | -8.39% |
| 2004 FY | 475.65 Million USD | -42.2% |
| 2003 Q4 | 822.92 Million USD | 3.26% |
| 2003 Q3 | 796.92 Million USD | -5.31% |
| 2003 Q2 | 841.61 Million USD | 38.08% |
| 2003 Q1 | 609.49 Million USD | -18.45% |
| 2003 FY | 822.92 Million USD | 10.11% |
| 2002 Q4 | 747.35 Million USD | 41.4% |
| 2002 Q1 | 440.01 Million USD | 853.21% |
| 2002 Q3 | 528.52 Million USD | -4.87% |
| 2002 Q2 | 555.6 Million USD | 26.27% |
| 2002 FY | 747.35 Million USD | 1519.01% |
| 2001 Q4 | 46.16 Million USD | -88.57% |
| 2001 FY | 46.16 Million USD | -93.75% |
| 2001 Q1 | 613.5 Million USD | -16.95% |
| 2001 Q2 | 570.39 Million USD | -7.03% |
| 2001 Q3 | 403.96 Million USD | -29.18% |
| 2000 Q2 | 301.29 Million USD | -0.01% |
| 2000 FY | 738.72 Million USD | 437.26% |
| 2000 Q1 | 301.31 Million USD | 119.14% |
| 2000 Q4 | 738.72 Million USD | 145.82% |
| 2000 Q3 | 300.51 Million USD | -0.26% |
| 1999 Q2 | 126.7 Million USD | 0.16% |
| 1999 Q3 | 126.2 Million USD | -0.39% |
| 1999 Q4 | 137.5 Million USD | 8.95% |
| 1999 FY | 137.5 Million USD | 8.35% |
| 1999 Q1 | 126.5 Million USD | -0.32% |
| 1998 Q1 | 19.3 Million USD | 293.88% |
| 1998 Q3 | 15.2 Million USD | 31.03% |
| 1998 Q2 | 11.6 Million USD | -39.9% |
| 1998 FY | 126.9 Million USD | 2489.8% |
| 1998 Q4 | 126.9 Million USD | 734.87% |
| 1997 Q1 | 6 Million USD | -14.29% |
| 1997 Q4 | 4.9 Million USD | -9.26% |
| 1997 Q3 | 5.4 Million USD | -5.26% |
| 1997 Q2 | 5.7 Million USD | -5.0% |
| 1997 FY | 4.9 Million USD | -30.0% |
| 1996 Q2 | 9.7 Million USD | -3.96% |
| 1996 Q3 | 9.2 Million USD | -5.15% |
| 1996 Q4 | 7 Million USD | -23.91% |
| 1996 Q1 | 10.1 Million USD | -0.98% |
| 1996 FY | 7 Million USD | -31.37% |
| 1995 Q4 | 10.2 Million USD | 0.28% |
| 1995 FY | 10.2 Million USD | -9.73% |
| 1995 Q3 | 10.17 Million USD | -0.19% |
| 1995 Q1 | 5.4 Million USD | -52.21% |
| 1995 Q2 | 10.19 Million USD | 88.71% |
| 1994 Q4 | 11.3 Million USD | 0.0% |
| 1994 FY | 11.3 Million USD | -47.69% |
| 1993 FY | 21.6 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 2.75 Billion USD | -713.954% |
| Catalent, Inc. | 4.98 Billion USD | -348.837% |
| Emergent BioSolutions Inc. | 877.5 Million USD | -2451.339% |
| Elanco Animal Health Incorporated | 5.77 Billion USD | -287.738% |
| Perrigo Company plc | 4.07 Billion USD | -449.615% |
| Teva Pharmaceutical Industries Limited | 20.15 Billion USD | -11.09% |
| Zoetis Inc. | 6.8 Billion USD | -229.09% |